Sandoz to Engage With U.S. Policymakers After Trump's Tariff Plan
Hikma Rx chief commercial officer says division targets complex generics, innovative products
Health care roundup: Market talk
Hikma Pharmaceuticals (HIK) Initiated with a Buy at Citi
Hikma Cancels More Shares as $250m Buyback Passes 10 Million Mark
Hikma Pharmaceuticals (HIK) Receives a Buy from Deutsche Bank